Home / ASTRAZEN.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ASTRAZEN.NS make money? Does ASTRAZEN.NS have pricing power? What's the Earnings Whisper? Will ASTRAZEN.NS profit more as the business scales? What is ASTRAZEN.NS's management track record? Is ASTRAZEN.NS's current price justified?

AstraZeneca Pharma India Limited

₹5970.5 -$2807.00 (-31.98%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹5937

Day Range

₹5843.5₹6009

Year Range

₹5640₹9849.5

Market Cap

149.26B

AVG Volume

10.91K

Trailing/Forward PE

88/179.08

PEG ratio

-11.76

Dividend Yield

0.60%

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

ASTRAZEN.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	6.83B
26 Q4	5.79B
26 Q3	6.12B
26 Q2	5.59B
26 Q1	5.26B
25 Q4	4.77B
25 Q3	4.4B
25 Q2	4.08B
25 Q1	3.88B
24 Q4	3.83B

Net Income (INR) · Q

ASTRAZEN.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	379.3M
26 Q4	448.8M
26 Q3	325.9M
26 Q2	542.2M
26 Q1	558.3M
25 Q4	582.5M
25 Q3	308.5M
25 Q2	384.3M
25 Q1	-117.9M
24 Q4	394.79M

Operating Income (INR) · Q

ASTRAZEN.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	437.1M
26 Q4	553.1M
26 Q3	409.9M
26 Q2	726.1M
26 Q1	645.4M
25 Q4	695.1M
25 Q3	679.2M
25 Q2	432.2M
25 Q1	341.6M
24 Q4	475.45M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

AstraZeneca Pharma India Limited

Video analysis: ASTRAZEN.NS

News: ASTRAZEN.NS

Similar companies